Paradigm Financial Advisors buys $623,100 stake in Monsanto Company (MON)

Monsanto Company (MON) : Paradigm Financial Advisors scooped up 554 additional shares in Monsanto Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 26, 2016. The investment management firm now holds a total of 5,837 shares of Monsanto Company which is valued at $623,100.Monsanto Company makes up approximately 0.37% of Paradigm Financial Advisors’s portfolio.

Other Hedge Funds, Including , Seaward Management Limited Partnership reduced its stake in MON by selling 1,935 shares or 4.46% in the most recent quarter. The Hedge Fund company now holds 41,492 shares of MON which is valued at $4,429,271. Monsanto Company makes up approx 0.23% of Seaward Management Limited Partnership’s portfolio. Donald L. Hagan sold out all of its stake in MON during the most recent quarter. The investment firm sold 294 shares of MON which is valued $31,070.Acropolis Investment Management reduced its stake in MON by selling 314 shares or 8.96% in the most recent quarter. The Hedge Fund company now holds 3,192 shares of MON which is valued at $339,756. Monsanto Company makes up approx 0.06% of Acropolis Investment Management’s portfolio.Bristol John W Co Inc Ny reduced its stake in MON by selling 34,361 shares or 5.45% in the most recent quarter. The Hedge Fund company now holds 596,188 shares of MON which is valued at $63,458,251. Monsanto Company makes up approx 1.73% of Bristol John W Co Inc Ny’s portfolio.

Monsanto Company opened for trading at $106.09 and hit $107.07 on the upside on Friday, eventually ending the session at $106.77, with a gain of 0.61% or 0.65 points. The heightened volatility saw the trading volume jump to 19,61,914 shares. Company has a market cap of $46,720 M.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.